Easy discrimination of hematogones from lymphoblasts in B-cell progenitor acute lymphoblastic leukemia patients using CD81/CD58 expression ratio.

Carole NagantDaniele CasulaAnne JanssensVo Thanh Phuong NguyenBrigitte Cantinieaux

Published in: International journal of laboratory hematology (2018)

We demonstrate in this study that routine use of the MFI antigen ratio (CD81/CD58) in addition to the MFC evaluation using WHO classical criteria appears to be an efficient approach to discriminate LB from HG.

Keyphrases

acute lymphoblastic leukemia
end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
poor prognosis
peritoneal dialysis
patient reported outcomes